Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 17: | Line 17: | ||
* Raltitrexed | * Raltitrexed | ||
=====[[Epidermal Growth Factor Receptor]] Inhibitor===== | =====[[Epidermal Growth Factor Receptor]] Inhibitor===== | ||
| - | * [[Herceptin]] - Generic: Trastuzumab | + | * [[Herceptin]] - Generic: [[Trastuzumab]] |
| - | * [[Iressa]] - Generic: Gefitinib | + | * [[Iressa]] - Generic: [[Gefitinib]] |
| - | * [[Tarceva]] - Generic: Erlotinib | + | * [[Tarceva]] - Generic: [[Erlotinib]] |
* [[Tykerb]] - Generic: [[Lapatinib]] | * [[Tykerb]] - Generic: [[Lapatinib]] | ||
=====Estrogen Receptor Modulator===== | =====Estrogen Receptor Modulator===== | ||
* Evista - Generic: Raloxifene | * Evista - Generic: Raloxifene | ||
* Fareston - Generic: Toremifene | * Fareston - Generic: Toremifene | ||
| - | * [[Nolvadex]] - Generic: Tamoxifen | + | * [[Nolvadex]] - Generic: [[Tamoxifen]] |
| - | =====Multiple Receptor Tyrosine | + | =====Multiple Receptor [[Tyrosine kinase]] ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) Inhibitor===== |
| - | * [[Gleevec]] - Generic: Imatinib | + | * [[Gleevec]] - Generic: [[Imatinib]] |
| - | * [[Nexavar]] - Generic: Sorafenib | + | * [[Nexavar]] - Generic: [[Sorafenib]] |
| - | * [[Sprycel]] - Generic: Dasatinib | + | * [[Sprycel]] - Generic: [[Dasatinib]] |
| - | * [[Sutent]] - Generic: Sunitinib | + | * [[Sutent]] - Generic: [[Sunitinib]] |
* [[Tasigna]] - Generic: [[Nilotinib]] | * [[Tasigna]] - Generic: [[Nilotinib]] | ||
=====[[Vascular Endothelial Growth Factor]] Inhibitor===== | =====[[Vascular Endothelial Growth Factor]] Inhibitor===== | ||
| - | * [[Avastin]] - Generic: Bevacizumab | + | * [[Avastin]] - Generic: [[Bevacizumab]] |
</td> | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
__NOTOC__ | __NOTOC__ | ||
Revision as of 07:56, 24 January 2019
Anti-CD20 Monoclonal Antibody
Anti-melanoma Monoclonal Antibody
B-Raf Kinase Inhibitor
Chemotherapy
Dihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor ModulatorMultiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
